(LARGO, FL) PharmaLink, Inc., an Industry-leading pharmaceutical reverse distributor, announced today a new contract relationship with biopharmaceutical manufacturer Merck Sharp & Dohme LLC (Merck). The new Returns Processing Service Agreement is expected to enhance the returns process for downstream customers while maintaining the integrity of supply chain security.
(LARGO, FL) PharmaLink, Inc., a leading pharmaceutical reverse distributor, announced today its acquisition of Cybornetic Systems, Inc. dba PharmaReturns, Inc. In addition to expanding its national account base with top tier clients, the purchase provides PharmaLink with an innovative technology platform for returns processing that adds Artificial Intelligence (AI) and new levels of customization to the reverse distribution process for pharmaceutical manufacturers. The Internet Managed Product Returns Solution (IMPRS) currently supports returns processing operations for over 400 Pharmaceutical manufacturers in the United States.
Largo, FL. – February 2023- Industry leading pharmaceutical returns management company, PharmaLink, Inc. announced today that it has completed its second expansion of its current headquarters and processing location in Largo, Florida. The expansion increases its overall capacity to 91,000 square feet at its current facility and will substantially augment its processing and product storage capacity.
September 2, 2021 – PharmaLink, Inc., an industry-leading pharmaceutical reverse distributor, is proud to announce a new contract relationship with biopharmaceutical manufacturer Amgen. The new Returns Processing and Recall Management service agreement enhances the returns process for downstream customers while maintaining the integrity of supply chain security.
“I am pleased to welcome Susan to the PharmaLink family,” said Thierry Beckers, President & CEO at PharmaLink. “Her exceptional talents and diverse leadership experience will position her as an asset to our growing organization.”
PharmaLink’s series of expansion initiatives have continued to progress since the launch in March 2020. Phase I was comprised of moving the designated operations and administrative functions to a new area. Once that move was completed, space became available to begin planning and implementing Phase II.
As the landscape of the reverse logistics industry continues to foster dynamic changes to regulations and yield new service opportunities to pharmacies nationwide, we have developed a digital content library featuring free videos, whitepapers, brochures, articles and press releases.
As we continue to navigate through the COVID-19 pandemic, we have experienced some of the most challenging and uncertain times in recent history. This crisis has required us to take bold actions to preserve the safety and welfare of our employees and customers.
PharmaLink Announces Facility Expansion to Accommodate Growth Largo, FL.– December 17, 2019 — PharmaLink, Inc., an industry leading pharmaceutical reverse distribution company, is announcing a series of initiatives designed to accommodate the changing dynamics of its business and the industry. Today, PharmaLink announced that it started Phase 1 of its expansion project in response to
Join Thierry Beckers, President & COO, Gil Kanner, Vice President, Operations, Hilmer Beckers, Chairman & CEO, and Adam Bottie, Vice President, Sales & Business Development, as they discuss PharmaLink’s services; the nation’s premier pharmaceutical returns processor in RxInsider’s Thought Leadership Series.